Univest
Univest
  • Markets

Wockhardt Ltd. (WOCKPHARMA): Wockhardt Ltd Share Price Rises 3.27% to Rs 1,941.75

  • August 27, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
Wockhardt Ltd Share Price
Wockhardt Ltd. (WOCKPHARMA) share price rose to Rs 1,941.75 today, up 3.27% from the previous close. Market cap was Rs 30,822.33 crore.

Published: 27 August 2026 at 12:41:17 PM IST

Wockhardt Ltd Share Price rose today to Rs 1,941.75, up 3.27% from the previous close of Rs 1,880.25, while the company’s market capitalisation stood at Rs 30,822.33 crore. The move took the stock above its opening price of Rs 1,892 and close to the day’s high of Rs 1,950, with the low at Rs 1,872.30. The data confirms a same-day share price gain, but it does not establish a company-specific catalyst. In Wockhardt Ltd Stock News, the focus today is on the price move, the turnover of Rs 3.92 crore and how the stock compares with healthcare peers on valuation, return ratios and size. Univest is tracking the event through Wockhardt Ltd Share Price Today coverage, with the verified numbers providing the clearest view of why the stock is in Stocks in News and Top Gainers Today searches.

The broader read from Wockhardt Ltd Share Price Today is straightforward: the stock added Rs 61.50 in a single session, and the day’s range of Rs 1,872.30 to Rs 1,950 shows where it traded during the move. Since no company-specific trigger is supplied, the article relies on verified market data, sector context and peer comparison rather than speculation. Univest is using the same figures to frame Wockhardt Ltd Share Price, Wockhardt Ltd Stock News and Wockhardt Ltd Share Price Update for readers who want a factual market note rather than a narrative built on assumptions.

Table of Contents

Toggle
  • Wockhardt Ltd Share Price Today: Price Action Analysis
  • Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Wockhardt
  • About Wockhardt
  • Track Wockhardt Ltd Share Price on Univest
  • Frequently Asked Questions
    • Why did Wockhardt Ltd share price rise today?
    • What is Wockhardt Ltd share price today?
    • What is Wockhardt Ltd market cap?
    • How does Wockhardt compare with healthcare peers?
    • What do Wockhardt valuation ratios show?
    • What does Wockhardt's profitability data show?
    • What does Wockhardt do?
    • How can I track Wockhardt Ltd share price on Univest?

Wockhardt Ltd Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,941.75
Previous Close Rs 1,880.25
Today's Move Rs 61.5 (+3.27%)
Open Rs 1,892
High Rs 1,950
Low Rs 1,872.3
Turnover Rs 3.92 crore
Market Capitalisation Rs 30,822.33 crore
Market Cap Category Large Cap

Wockhardt Ltd. (WOCKPHARMA) rose to Rs 1,941.75 from the previous close of Rs 1,880.25, a move of Rs 61.5 or 3.27%. The stock opened at Rs 1,892, reached a high of Rs 1,950, recorded a low of Rs 1,872.3.

Wockhardt Ltd Share Price Today closed higher by Rs 61.50, or 3.27%, at Rs 1,941.75 after opening at Rs 1,892. The stock moved between Rs 1,872.30 and Rs 1,950 during the session, which keeps the day’s move firmly event-led and measurable. The previous close was Rs 1,880.25, so the day’s change is fully explained by the supplied market data and not by any unverified trigger. In Wockhardt Ltd Share Price News, the rise also places the stock among the names being watched in Share Market Today and Indian Stock Market screens for session-wise gainers. Univest is presenting the price action as a verified same-day move, with no extra narrative attached to the numbers.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 30,822.33 crore
P/E Ratio 74.7x
P/B Ratio 6.07x
ROE 4.29%
ROCE 6.79%
EPS Rs 25.17
Book Value Per Share Rs 309.81
Dividend Yield 0%

Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 74.7x, P/B 6.07x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.

Wockhardt Ltd. has a market capitalisation of Rs 30822.33 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 74.7x, P/B at 6.07x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.58x, median ROE of 11.87%, median ROCE of 13.88%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 74.7x
Benchmark Median P/E 30.58x
Benchmark Average P/E 47.16x
Benchmark P/E Range 3.19x to 671.51x
Company P/B Ratio 6.07x
Benchmark Median P/B 2.76x
Company ROE 4.29%
Benchmark Median ROE 11.87%
Company ROCE 6.79%
Benchmark Median ROCE 13.88%
Company Market Capitalisation Rs 30,822.33 crore
Benchmark Median Market Cap Rs 644.16 crore

Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 74.7x, which is above the benchmark median of 30.58x, a difference of +144.28%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.87%, a difference of -63.86%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.88%, a difference of -51.08%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,59,952.51 37.71 5.27 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,30,426.73 81.82 13.55 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,87,140.99 85.25 20.71 26.76 19.27
Cipla Ltd. CIPLA 1,14,715.15 33.76 3.24 11.83 16
Zydus Lifesciences Ltd. ZYDUSLIFE 1,12,717.93 25.37 4.25 19.69 21.39

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 74.7x compared with the displayed peer median of 37.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 30,822.33 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Wockhardt

  • Wockhardt Ltd Share Price rose 3.27% today to Rs 1,941.75 after closing above the previous close of Rs 1,880.25.
  • The session range was Rs 1,872.30 to Rs 1,950, with opening price at Rs 1,892 and turnover of Rs 3.92 crore.
  • Market capitalisation stands at Rs 30,822.33 crore, placing the company well above the same-industry median market cap of Rs 644.16 crore.
  • P/E of 74.7 and P/B of 6.07 sit above the same-industry medians of 30.58 and 2.76 respectively.
  • ROE of 4.29% and ROCE of 6.79% are below the sector median return ratios, which keeps Wockhardt Ltd Fundamental Analysis in focus.

About Wockhardt

Wockhardt Ltd is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. The company works in a segment where market participants often compare valuation, earnings and return ratios across branded and generic pharma names. Based on the supplied data, Wockhardt’s business context is framed by its listed-market identity rather than a detailed segment breakup, so the important points here are its sector, industry and financial positioning. The company’s market capitalisation of Rs 30,822.33 crore places it well above the benchmark median for the same industry, while its P/E, P/B, ROE, ROCE, EPS and book value shape how Wockhardt Ltd Share Price is read in the market. For readers tracking Wockhardt Ltd Company News, the company’s profile is best understood through its place in healthcare and its current valuation metrics.

Track Wockhardt Ltd Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Wockhardt Ltd Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. Univest also brings together Wockhardt Ltd Share Price Today coverage, Wockhardt Ltd Stock News and Wockhardt Ltd Share Price Update so readers can follow the stock with a single verified reference point.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why did Wockhardt Ltd share price rise today?

Ans. Wockhardt Ltd Share Price rose 3.27% to Rs 1,941.75, but the supplied data does not establish a company-specific catalyst. The verified move is supported by the day’s open, high, low and previous close.

What is Wockhardt Ltd share price today?

Ans. Wockhardt Ltd Share Price Today is Rs 1,941.75. The stock gained Rs 61.50 from the previous close of Rs 1,880.25, and the session high was Rs 1,950. The previous close was Rs 1,880.25.

What is Wockhardt Ltd market cap?

Ans. Wockhardt Ltd Market Cap stands at Rs 30,822.33 crore. That places the company above the same-industry median market capitalisation of Rs 644.16 crore and above the benchmark average of Rs 13,791.94 crore.

How does Wockhardt compare with healthcare peers?

Ans. Wockhardt trades at a higher P/E than Cipla and Zydus Lifesciences, but below Divi's Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are lower than all five listed peers in the comparison set.

What do Wockhardt valuation ratios show?

Ans. Wockhardt's P/E is 74.7 and P/B is 6.07, while EPS is 25.17 and book value is Rs 309.81. The stock is priced richer than the same-industry median on both valuation measures.

What does Wockhardt's profitability data show?

Ans. Wockhardt reports ROE of 4.29% and ROCE of 6.79%, both below the same-industry medians. That makes profitability and capital efficiency a key context for Wockhardt Ltd Stock Analysis. ROE stands at 4.29%.

What does Wockhardt do?

Ans. Wockhardt is a Healthcare company in the Pharmaceuticals & Drugs industry. Based on the supplied data, its market context is best understood through valuation, earnings and sector comparison rather than segment details.

How can I track Wockhardt Ltd share price on Univest?

Ans. Univest tracks Wockhardt Ltd Share Price, share price updates, fundamental ratios, shareholding pattern and market insights. It gives readers one place to review the stock alongside sector and peer context.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply